Trial: 201908124

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Phase

I

Principal Investigator

Gillanders, William

Disease Site

Pancreas

Learn more about this study at: clinicaltrials.gov